It was reported yesterday that GreenLight Biosciences Inc, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, has named Susan Keefe as its new chief financial officer.
The new chief financial officer is to lead the company's financial strategy and facilitate its growth plan, and will be responsible for managing all aspects of GreenLight's financial operations.
Prior to joining GreenLight, Keefe worked for 25 years in financial positions across the biotech, consumer packaged goods and health care industries. Most recently, she served as financial consultant to a range of life science companies with Danforth Advisors.
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
WuXi Biologics honoured for water security by CDP
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services